Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 224 Records) |
| Query Trace: Leukemia and IDH1[original query] |
|---|
| Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. Journal of hematology & oncology 2022 09 15 (1): 126. Kunadt Desiree, Stasik Sebastian, Metzeler Klaus H, Röllig Christoph, Schliemann Christoph, Greif Philipp A, Spiekermann Karsten, Rothenberg-Thurley Maja, Krug Utz, Braess Jan, Krämer Alwin, Hochhaus Andreas, Scholl Sebastian, Hilgendorf Inken, Brümmendorf Tim H, Jost Edgar, Steffen Björn, Bug Gesine, Einsele Hermann, Görlich Dennis, Sauerland Cristina, Schäfer-Eckart Kerstin, Krause Stefan W, Hänel Mathias, Hanoun Maher, Kaufmann Martin, Wörmann Bernhard, Kramer Michael, Sockel Katja, Egger-Heidrich Katharina, Herold Tobias, Ehninger Gerhard, Burchert Andreas, Platzbecker Uwe, Berdel Wolfgang E, Müller-Tidow Carsten, Hiddemann Wolfgang, Serve Hubert, Stelljes Matthias, Baldus Claudia D, Neubauer Andreas, Schetelig Johannes, Thiede Christian, Bornhäuser Martin, Middeke Jan M, Stölzel Friedrich, |
| Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 2022 Aug . Lachowiez Curtis A, Reville Patrick K, Kantarjian Hagop, Jabbour Elias, Borthakur Gautam, Daver Naval, Issa Ghayas, Furudate Ken, Tanaka Tomoyuki, Pierce Sherry, Tang Guilin, Patel Keyur P, Medeiros Jeffrey, Abbas Hussein A, Haddad Fadi, Hammond Daniel, Short Nicholas J, Maiti Abhishek, Yilmaz Musa, Sasaki Koji, Takahashi Koichi, Pemmaraju Naveen, Konopleva Marina, Garcia-Manero Guillermo, Ravandi Farhad, Kadia Tapan M, Loghavi Sanam, DiNardo Courtney |
| Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
| Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer 2022 Sep . Ball Somedeb, Knepper Todd C, Deutsch Yehuda E, Samra Wassim, Watts Justin M, Bradley Terrence J, Chan Onyee, Hussaini Mohammad Omar, Zhang Ling, Sweet Kendra L, Kuykendall Andrew T, Talati Chetasi, Padron Eric, Komrokji Rami S, Lancet Jeffrey E, Sallman David |
| Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia. Clinical interventions in aging 2022 17 1187-1197. Li Fengli, Li Na, Wang Anyou, Liu X |
| [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations]. Zhongguo shi yan xue ye xue za zhi 2022 6 30 (3): 659-670. Xia Pei-Hui, Xu Zi-Jun, Jin Ye, Ma Ji-Chun, Wen Xiang-Mei, Yuan Qian, Leng Jia-Yan, Qian Jun, Lin Jia |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
| Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Journal of clinical medicine 2022 5 11 (9): . Kang Dain, Jung Jin, Park Silvia, Cho Byung-Sik, Kim Hee-Je, Kim Yeojae, Lee Jong-Mi, Kim Hoon Seok, Ahn Ari, Kim Myungshin, Kim Yongg |
| Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions. Turkish journal of haematology : official journal of Turkish Society of Haematology 2022 4 39 (2): 84-93. Qin Wei, Chen Xiayu, Shen Hong Jie, Wang Zheng, Cai Xiaohui, Jiang Naike, Hua Haiyi |
| Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia. The New England journal of medicine 2022 4 386 (16): 1519-1531. Montesinos Pau, Recher Christian, Vives Susana, Zarzycka Ewa, Wang Jianxiang, Bertani Giambattista, Heuser Michael, Calado Rodrigo T, Schuh Andre C, Yeh Su-Peng, Daigle Scott R, Hui Jianan, Pandya Shuchi S, Gianolio Diego A, de Botton Stephane, Döhner Hartm |
| Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia. Leukemia research 2022 12 124 107002. Zhou Qianghua, Zhao Davidson, Eladl Entsar, Capo-Chichi Jose-Mario, Kim Dennis Dong Hwan, Chang Ho |
| BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
| Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia. Journal of internal medicine 2022 10 293 (3): 329-339. Weng Guangyang, Zhang Yu, Yu Guopan, Luo Tingyue, Yu Sijian, Xu Na, Sun Zhiqiang, Lin Dongjun, Deng Lan, Liang Xinquan, Xiao Jie, Zhang Hongyu, Guo Ziwen, Shao Ruoyang, Du Xin, Jin Hua, Liu Qi |
| Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences 2023 9 . Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambind |
| Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
| Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European journal of haematology 2023 7 . Valentina Giudice, Bianca Serio, Santa Errichiello, Idalucia Ferrara, Alessandra Galdiero, Angela Bertolini, Roberta Visconti, Danilo De Novellis, Roberto Guariglia, Serena Luponio, Denise Morini, Anna Maria Della Corte, Anna Maria Sessa, Francesco Verdesca, Maddalena Langella, Barbara Izzo, Carmine Selle |
| The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 2023 7 18 (7): e0289014. Sohaib M Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N Al-Eit |
| Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia. American journal of clinical pathology 2023 7 . Joshua Tatarian, Natalie Tupper Bs, Peng Li, Julie Feusier, Maryam Abdo, Stephen Hyter, Patrick R Gonzales, Da Zhang, Janet Woodroof, Sarah Kelting, Andrew K Godwin, Wei C |
| Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
| Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis. Blood advances 2023 6 . Sara Zarnegar-Lumley, Todd Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda R Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P Radich, Frederick R Appelbaum, Era L Pogosova-Agadjanyan, Kristen M O'Dwyer, Martin S Tallman, Mark R Litzow, Ehab Atallah, Todd M Cooper, Richard Aplenc, Omar I Abdel-Wahab, Alan S Gamis, Selina M Luger, Harry P Erba, Ross L Levine, E Anders Kolb, Derek L Stirewalt, Soheil Meshinchi, Katherine Tarlo |
| Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances 2023 5 . Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley Orwick, Karilyn Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfe |
| DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 3 329 (9): 745-755. Dillon Laura W, Gui Gege, Page Kristin M, Ravindra Niveditha, Wong Zoë C, Andrew Georgia, Mukherjee Devdeep, Zeger Scott L, El Chaer Firas, Spellman Stephen, Howard Alan, Chen Karen, Auletta Jeffery, Devine Steven M, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Weisdorf Daniel J, Hourigan Christopher |
| Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clinical epigenetics 2023 3 15 (1): 54. Xu Xiaoyan, Wang Hong, Han Haohao, Yao Yifang, Li Xueqian, Qi Jiaqian, Cai Chengsen, Zhou Meng, Tang Yaqiong, Pan Tingting, Zhang Ziyan, Yang Jingyi, Wu Depei, Han Y |
| [Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 435-441. Wei Jifeng, Qiu Huiying, Zhou Hang, Chen Zhe, Miao Lei, Wang Ying, Zhao Lidong, Cai Zhim |
| Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & lymphoma 2023 3 1-9. Ramia de Cap Maximiliano, Wu Leo P, Hirt Christian, Pihan German A, Patel Sanjay S, Tam Wayne, Bueso-Ramos Carlos E, Kanagal-Shamanna Rashmi, Raess Philipp W, Siddon Alexa, Narayanan Damodaran, Morgan Elizabeth A, Pinkus Geraldine S, Mason Emily F, Hsi Eric D, Rogers Heesun J, Toth Laura, Foucar Kathryn, Hurwitz Stephanie N, Bagg Adam, Rets Anton, George Tracy I, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga K, |
| The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
| Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China. Cancer medicine 2023 2 . Li Junnan, Pei Li, Liang Simin, Xu Shuangnian, Wang Yi, Wang Xiao, Liao Yi, Zhan Qian, Cheng Wei, Yang Zesong, Tang Xiaoqiong, Zhang Hongbin, Xiao Qing, Chen Jianbin, Liu Lin, Wang |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients. Drug research 2023 1 73 (3): 146-155. Sabri Alaa, Omran Mervat M, Azim S Abdel, Abdelfattah Raafat, Allam Rasha Mahmoud, Shouman Samia |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: